Literature DB >> 18458934

Fundus autofluorescence after full macular translocation surgery for myopic choroidal neovascularization.

Miki Sawa1, Fumi Gomi, Masahito Ohji, Motokazu Tsujikawa, Takashi Fujikado, Yasuo Tano.   

Abstract

BACKGROUND: To investigate fundus autofluorescence (FAF) findings in patients who underwent full macular translocation surgery with 360-degree retinotomy (MT360) for myopic choroidal neovascularization (CNV).
METHODS: Observational case series. Thirty-one eyes of 31 patients who underwent MT360 for myopic CNV from February 1999 through September 2005 were included. We measured the best-corrected visual acuity and obtained color fundus photographs, optical coherence tomography (OCT) images, and fluorescein angiography images. FAF imaging by confocal scanning laser ophthalmoscope was obtained postoperatively in all study eyes and preoperatively in two study participants. FAF features at the new macula were qualitatively evaluated and compared with preoperative lesions associated with CNV. The FAF features at the retinal pigment epithelial (RPE) area with preoperative CNV also were evaluated.
RESULTS: The mean interval between MT360 and the final FAF examination was 58 months (range, 8-94 months). FAF imaging was almost normal in five eyes (16%), the increased FAF was well defined at the new macula area in 23 eyes (74%), and the FAF was decreased in three eyes (10%). Neither newly developed CNV nor subretinal fluid was seen at the new macular region in any eyes on fluorescein angiography or OCT imaging. The configurations of well-defined increased FAF in 23 eyes corresponded with the preoperative CNV in two eyes (9%) and subretinal hemorrhages in five eyes (22%). Well-defined increased FAF larger than the CNV or subretinal hemorrhage was seen in 16 eyes (69%). The RPE area located at the area of the preoperative CNV had a FAF defect or decreased FAF in 30 eyes (97%) on postoperative FAF imaging; there were no increased FAF changes.
CONCLUSIONS: Well-defined increased FAF at the new macula after MT360 suggests that FAF reflects not only fluorophores in the RPE but also in the neurosensory retina. These fluorophores may result from interactions between the retina and CNV/pathologic RPE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458934     DOI: 10.1007/s00417-008-0835-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  26 in total

1.  Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration.

Authors:  F G Holz; C Bellman; S Staudt; F Schütt; H E Völcker
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-04       Impact factor: 4.799

2.  Comparison of three techniques of foveal translocation in patients with subfoveal choroidal neovascularization resulting from age-related macular degeneration.

Authors:  M Ohji; T Fujikado; S Kusaka; A Hayashi; J Hosohata; Y Ikuno; M Sawa; A Kubota; N Hashida; Y Tano
Journal:  Am J Ophthalmol       Date:  2001-12       Impact factor: 5.258

3.  Retinal changes after macular translocation with 360-degree retinotomy in monkey eyes.

Authors:  Xiaoyun Fang; Atsushi Hayashi; Takeshi Morimoto; Shinichi Usui; Osman Cekic; Sayuri Fujioka; Nobutsugu Hayashi; Takashi Fujikado; Masahito Ohji; Yasuo Tano
Journal:  Am J Ophthalmol       Date:  2004-06       Impact factor: 5.258

4.  Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope.

Authors:  A von Rückmann; F W Fitzke; A C Bird
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-02       Impact factor: 4.799

5.  Foveal translocation: a comparison of two techniques.

Authors:  M Ohji; T Fujikado; Y Saito; J Hosohata; A Hayashi; Y Tano
Journal:  Semin Ophthalmol       Date:  1998-03       Impact factor: 1.975

6.  Abnormalities of fundus autofluorescence in central serous retinopathy.

Authors:  Andrea von Rückmann; Frederick W Fitzke; Joseph Fan; Anthony Halfyard; Alan C Bird
Journal:  Am J Ophthalmol       Date:  2002-06       Impact factor: 5.258

7.  Rapid recurrence of geographic atrophy after full macular translocation for nonexudative age-related macular degeneration.

Authors:  Rahul N Khurana; Gildo Y Fujii; Alexander C Walsh; Mark S Humayun; Eugene de Juan; Srinivas R Sadda
Journal:  Ophthalmology       Date:  2005-09       Impact factor: 12.079

8.  The biosynthesis of A2E, a fluorophore of aging retina, involves the formation of the precursor, A2-PE, in the photoreceptor outer segment membrane.

Authors:  J Liu; Y Itagaki; S Ben-Shabat; K Nakanishi; J R Sparrow
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

9.  Isolation and characterization of a retinal pigment epithelial cell fluorophore: an all-trans-retinal dimer conjugate.

Authors:  Nathan E Fishkin; Janet R Sparrow; Rando Allikmets; Koji Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

10.  A2-rhodopsin: a new fluorophore isolated from photoreceptor outer segments.

Authors:  Nathan Fishkin; Young-Pyo Jang; Yasuhiro Itagaki; Janet R Sparrow; Koji Nakanishi
Journal:  Org Biomol Chem       Date:  2003-04-07       Impact factor: 3.876

View more
  3 in total

1.  Structural and functional changes associated with normal and abnormal fundus autofluorescence in patients with retinitis pigmentosa.

Authors:  Vivienne C Greenstein; Tobias Duncker; Karen Holopigian; Ronald E Carr; Jonathan P Greenberg; Stephen H Tsang; Donald C Hood
Journal:  Retina       Date:  2012-02       Impact factor: 4.256

2.  SPECKLED HYPOAUTOFLUORESCENCE AS A SIGN OF RESOLVED SUBRETINAL HEMORRHAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Authors:  S Amal Hussnain; Rosa Dolz-Marco; Joshua L Dunaief; Christine A Curcio; K Bailey Freund
Journal:  Retina       Date:  2019-10       Impact factor: 4.256

Review 3.  Fundus autofluorescence applications in retinal imaging.

Authors:  Andrea Gabai; Daniele Veritti; Paolo Lanzetta
Journal:  Indian J Ophthalmol       Date:  2015-05       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.